Taiwan · Delayed Price · Currency is TWD Lotus Pharmaceutical Company Description
Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally.
Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease.
The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services.
Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization.
Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.
| Country | Taiwan |
| Founded | 1966 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Petar Vazharov |
Contact Details
Address: No. 277 Song Ren Road Taipei Taiwan | |
| Phone | 886 2 2700 5908 |
Stock Details
| Ticker Symbol | 1795 |
| Exchange | Taiwan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0001795003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Petar Antonov Vazharov | Chief Executive Officer and Director |
| Gwen Hsieh | Chief Information Officer |
| Bjartur Shen | Vice President of Strategies and Finance |
| Dr. Manish Chawla | Vice President of Research and Development |
| Eeling Chan CPA | Chief Financial Officer |
| Vamsi Kiran Kosaraju | Chief Operations Officer |
| Yi Ling Tian | Accounting Supervisor |
| Jeffrey Tsang | Head of Investor Relations and Corporate Communications |
| Edin Buljubasic | Vice President of Legal and Compliance |
| Fiona Lei | Head of Human Resources |